Corner Canyon uses Pharmacogenetic DNA testing to aid in assessing the correct medications for clients. Often clients who come in for treatment have tried medications that didn’t work for them, or have experienced significant side effects, and become discouraged about medication in general.
Corner Canyon also uses genetic testing for addiction. This assesses a client’s predisposition for addictive, compulsive, and impulsive behaviors.
Pharmacogenetic tests are essentially genetic testing for medication. During pharmacogenetic testing, tests are performed to evaluate a person’s potential response to a drug therapy. Most genetic testing has been used to help diagnose or predict the development of a genetic disease.
Genetic testing for medication is also commonly used because everyone responds to medication differently. The way we respond to medication could be due to the genes we have inherited.
Corner Canyon uses pharmacogenetic testing to quickly establish which medications are appropriate or inappropriate for clients, which enables us to get them on the correct medications, help them adjust to them, and stabilize under our supervision before resuming their lives after treatment. This improves outcomes and reduces the likelihood of relapse.
DNA medical tests can also help identify a client’s genetic predisposition to addictive behaviors. Substance abuse is very complicated, but ultimately it may come down to a combination of a person’s genes and environment.
Corner Canyon uses DNA Medical Tests for Addiction to help identify any genetic variants a client has. This shows what substances they are likely to abuse and what personality traits typically go along with their variants.
While a person’s genetic predispositions are not facts, they do help suggest what might develop in a client under a particular environment. For example, if a client with genetic predispositions towards using alcohol never drinks alcohol, they will not become an alcoholic.
Corner Canyon uses this DNA medical test to help clients and their family address stigma and denial. We also use this genetic testing to develop a relapse prevention plan once a client has completed their inpatient treatment.